Hostname: page-component-cb9f654ff-w5vf4 Total loading time: 0 Render date: 2025-08-29T17:19:57.921Z Has data issue: false hasContentIssue false
  • English
  • Français

Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study: commentary, Kuo et al

Published online by Cambridge University Press:  27 May 2025

Chun-ya Kuo ,
Po-Cheng Shih ,
Wan Ting Jiang Open the ORCID record for Wan Ting Jiang [Opens in a new window]  and
James Cheng-Chung Wei
Chun-ya Kuo
Affiliation:
Department of Psychiatry, Chung Shan Medical University Hospital, Taichung, Taiwan; and Department of Psychiatry, School of Medicine, Chung Shan Medical University, Taichung, Taiwan
Po-Cheng Shih
Affiliation:
Department of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
Wan Ting Jiang
Affiliation:
Chung Shan Medical University Hospital, Taichung, Taiwan
James Cheng-Chung Wei*
Affiliation:
Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; and Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan
*
Correspondence: James Cheng-Chung Wei. Email: WEI3228@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Psychotic disorders/schizophreniasuicidelipid-modifyingmortality and morbiditypsychological medicine

Information

Type
Commentary
Information
The British Journal of Psychiatry , Volume 226 , Issue 5 , May 2025 , pp. 324
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

*

These authors contributed equally.

References

Chen, P-H, Tsai, S-Y, Chen, P-Y, Pan, C-H, Su, S-S, Chen, C-C, et al. Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study. Br J Psychiatry [Epub ahead of print] 16 May 2024. Available from: https://doi.org/10.1192/bjp.2024.85.CrossRefGoogle ScholarPubMed
Plana-Ripoll, O, Pedersen, CB, Agerbo, E, Holtz, Y, Erlangsen, A, Canudas-Romo, V, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet 2019; 394: 1827–35.CrossRefGoogle ScholarPubMed
Correll, CU, Solmi, M, Croatto, G, Schneider, LK, Rohani-Montez, SC, Fairley, L, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 2022; 21: 248–71.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.